Analysis of Survival Data in Patients with Advanced Non-Small-Cell Lung Cancer Aged 60 Years and Over
FAN Xiaohong,GE Xiaoxiao,ZHAO Yizhuo,ZHANG Wei,YAN Bo,JIANG Liyan
DOI: https://doi.org/10.3969/j.issn.1008-6358.2013.03.049
2013-01-01
Abstract:Objective:To analyze the survival data and to investigate the prognostic factors of elderly patients aged 60 years and over with unresectable,advanced non-small cell lung cancer(NSCLC).Methods:The charts of 296 elderly(≥60 years) patients with unresectable,advanced NSCLC,diagnosed at the Pulmonary Department of Shanghai Chest Hospital affiliated to Shanghai Jiaotong University between Jan 2003 and Dec 2005 were retrospectively reviewed.Patients were divided into 4 groups based on age(60~64 years old(n=66),65~69 years old(n=93),70~74 years old(n=89) and over 75 years old(n=48).Patients' clinical characteristics,treatment and survival data were reviewed and analyzed to investigate the prognostic factors.Results: A total of 296 patients with advanced NSCLC were included.Male patients accounted for 73.0%.Adenocarcinoma accounted for 50.3%.Median overall survival(OS) was 13.20 months,the survival rate of 1-,2-,3-year were 53.0%,22.0%,4.0% respectively.No significant difference in survival rate and median survival was found among 4 groups(P=0.32).Gender,smoking history,histological type,clinical stage and PS score had no significant difference in the distribution among 4 groups by univariate analysis,while the percentages of patients combing with chronic diseases and receiving chemotherapy had significant differences(P<0.01).Partial correlation control analysis showed that there were significant correlations between chronic diseases and age(r1=0.1916,P<0.01),chemotherapy and age(r2=-0.2550,P<0.01),accepting effective treatment and chronic diseases(r3=-0.2003,P<0.01).Gender,histological type,clinical stage,PS score before chemotherapy affected the prognosis according to Cox multivariate analysis.Male,stage IV disease,PS score 2 and over were associated with a short survival time while adenocarcinoma derived significant survival benefit.Conclusions: Gender,stage of disease,performance status and histology are independent prognostic factors for elderly patients with advanced NSCLC.